A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of Endometriosis
This study evaluated serum biomarkers in 90 women and found that elevated levels of IL-6, TNF-α, hs-CRP, MCP-1, LIF, Glycodelin, Activin A, and CA-125 were associated with surgically confirmed endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study developed and validated a serum biomarker signature to enable the non-invasive diagnosis of endometriosis. The researchers analyzed specific protein markers in blood samples from patients with confirmed endometriosis compared to healthy controls, demonstrating high sensitivity and specificity in their diagnostic model. The findings indicate that this serum-based approach offers a viable alternative to invasive surgical procedures for identifying the disease. This paper is centrally about endometriosis — specifically focusing on a novel non-invasive diagnostic tool using serum biomarkers.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
521 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00